Bacterial #946;-Ketoacyl-Acyl Carrier Protein Synthase III (FabH): An Attractive Target for the Design of New Broad-Spectrum Antimicrobial Agents

Publisher： Bentham Science Publishers

E-ISSN： 1875-5607|8|1|36-45

ISSN： 1389-5575

Source： Mini Reviews in Medicinal Chemistry, Vol.8, Iss.1, 2008-01, pp. : 36-45

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Bacterial &bgr;-Ketoacyl-Acyl Carrier Protein Synthase III (FabH) as a Target for Novel Antibacterial Agents Design

By  

Current Medicinal Chemistry, Vol. 22, Iss. 5, 2015-02 ,pp. : 651-667

Bentham Science Publishers

Access to resources Recommend Favorite

Advances in the Research of &bgr;-Ketoacyl-ACP Synthase III (FabH) Inhibitors

By  

Current Medicinal Chemistry, Vol. 19, Iss. 8, 2012-03 ,pp. : 1225-1237

Bentham Science Publishers

Access to resources Recommend Favorite

Identification of Inhibitors of Bacterial Enoyl-Acyl Carrier Protein Reductase

By  

Current Drug Targets - Infectious Disorders, Vol. 5, Iss. 3, 2005-09 ,pp. : 297-305

Bentham Science Publishers

Access to resources Recommend Favorite

Ring-Expanded (“Fat”) Nucleosides as Broad-Spectrum Anticancer and Antiviral Agents

By  

Current Topics in Medicinal Chemistry, Vol. 2, Iss. 10, 2002-10 ,pp. : 1093-1109

Bentham Science Publishers

Access to resources Recommend Favorite

Matrix Metalloproteinase Inhibitors: New Challenges in the Era of Post Broad-Spectrum Inhibitors

By  

Current Pharmaceutical Design, Vol. 13, Iss. 20, 2007-07 ,pp. : 2087-2100

Bentham Science Publishers

Access to resources Recommend Favorite